Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases — CDC
3/3
FILE PHOTO: People wear masks as a protection against the coronavirus disease (COVID-19) pandemic in New York City, New York, U.S., December 12, 2022. REUTERS/Eduardo Munoz
2/3
PFE
-0.38%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
MRNA
-1.86%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
(Reuters) — The Omicron subvariant XBB.1.5 has likely become the dominant variant in the United States, accounting for 61.3% of COVID cases in the week ended Jan. 28, data from the U.S. Centers for Disease Control and Prevention showed on Friday.
The subvariant accounted for 49.5% of cases in the week ended Jan. 21, estimates from CDC showed.
XBB.1.5, which is currently the most transmissible variant, is an offshoot of XBB, first detected in October.
The now-dominant XBB-related subvariants are derived from the BA.2 version of Omicron.
An analysis from CDC showed on Wednesday that updated COVID-19 boosters from Pfizer (NYSE:PFE) Inc/BioNTech SE and Moderna (NASDAQ:MRNA) helped prevent symptomatic infections against the new XBB-related subvariants.
